AN2’s poison pill; Pfizer shares promising mid-stage data for flu shot

Plus, news about Vericel:

AN2 Therapeutics adopts poison pill: The small molecule drugmaker put forth the stockholder rights plan for a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

As it deepens immunology bets, Sanofi inks small molecule pact with Belharra

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 19, 2024

These are the bird flu questions that influenza and animal scientists desperately want answered

Ten weeks after government scientists discovered that H5N1 bird flu was sickening dairy cattle in the United States, many of the mysteries surrounding what is

June 5, 2024

A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.